Catuxa Prado Cueto-rekin lankidetzan egindako argitalpenak (10)

2014

  1. IFNα serum levels are associated with endothelial progenitor cells imbalance and disease features in rheumatoid arthritis patients

    PLoS ONE, Vol. 9, Núm. 1

2013

  1. Relationship between FOXP3 positive populations and cytokine production in systemic lupus erythematosus

    Cytokine, Vol. 61, Núm. 1, pp. 90-96

2012

  1. Circulating endothelial cells and their progenitors in systemic lupus erythematosus and early rheumatoid arthritis patients

    Rheumatology (United Kingdom), Vol. 51, Núm. 10, pp. 1775-1784

  2. Effects of glucocorticoid treatment on CD25 -FOXP3 + population and cytokine-producing cells in rheumatoid arthritis

    Rheumatology (United Kingdom), Vol. 51, Núm. 7, pp. 1198-1207

2011

  1. Dexamethasone upregulates FOXP3 expression without increasing regulatory activity

    Immunobiology, Vol. 216, Núm. 3, pp. 386-392

  2. Glucocorticoids enhance Th17/Th1 imbalance and signal transducer and activator of transcription 3 expression in systemic lupus erythematosus patients

    Rheumatology, Vol. 50, Núm. 10, pp. 1794-1801

2010

  1. Cytokines and regulatory T cells in rheumatoid arthritis and their relationship with response to corticosteroids

    Journal of Rheumatology, Vol. 37, Núm. 12, pp. 2502-2510

  2. Interleukin 10 and tumor necrosis factor-α genotypes in rheumatoid arthritis - Association with clinical response to glucocorticoids

    Journal of Rheumatology, Vol. 37, Núm. 3, pp. 503-511

2009

  1. Conserved anti-proliferative effect and poor inhibition of TNFα secretion by regulatory CD4+CD25+ T cells in patients with systemic lupus erythematosus

    Clinical Immunology, Vol. 132, Núm. 3, pp. 385-392

2008

  1. Influence of functional interleukin 10/tumor necrosis factor-α polymorphisms on interferon-α, IL-10, and regulatory T cell population in patients with systemic lupus erythematosus receiving antimalarial treatment

    Journal of Rheumatology, Vol. 35, Núm. 8, pp. 1559-1566